Redhill Biopharma
RDHL
#11160
Rank
S$3.22 M
Marketcap
S$0.36
Share price
-13.08%
Change (1 day)
-73.34%
Change (1 year)

Redhill Biopharma (RDHL) - Total debt

Total debt on the balance sheet as of June 2026 : S$1.38 Million

According to Redhill Biopharma's latest financial reports the company's total debt is S$1.38 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Redhill Biopharma - Total debt on balance sheet (from 2018 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$1.37 M183.9%
2024-12-31S$0.48 M-68.76%
2023-12-31S$1.54 M-99.06%
2022-12-31S$0.16 B38.55%
2021-12-31S$0.11 B3.26%
2020-12-31S$0.11 B2135.28%
2019-12-31S$5.14 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Sanofi
SNY
S$34.71 B 2,502,969.77%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$69.53 B 5,014,411.63%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$40.55 B 2,924,355.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$21.76 B 1,569,574.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
S$2.51 M 81.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel